Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00771264 · ClinicalTrials.gov registry record · Phase 4

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

A Phase 4 study, sponsored by Uroplasty.

Completed
Registry status
Phase 4
Development phase
220
Enrollment target

NCT00771264: Completed Phase 4 study, sponsored by Uroplasty.

NCT00771264 is a Phase 4 study that has completed, run by Uroplasty. The registered enrollment target is 220 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00771264, a Phase 4 study, has completed, sponsored by Uroplasty.

COMPLETED
Registry status
Phase 4
Development phase
220 participants
Enrollment target

Study Summary

The purpose of this study is to demonstrate superiority of percutaneous posterior tibial nerve stimulation (PTNS) therapy compared to sham therapy for the treatment of patients with overall bladder (OAB) symptoms.

Primary Outcome

A responder was defined as reporting bladder symptoms as moderately or markedly improved on a 7-level GRA at week 13 after completing 12, 30-minute, consecutive weekly intervention sessions.

Interventions

  • DEVICE Urgent PC Neuromodulation System

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2008-09
Est. Completion 2009-06
Phase Phase 4
Uroplasty

4 total trials

What the finished NCT00771264 record still lists

NCT00771264 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% lower).

The record links to 0 conditions, and to 1 intervention - of which Urgent PC Neuromodulation System is the first listed.

NCT00771264 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00771264 about?

NCT00771264 is a clinical study titled "Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms". The purpose of this study is to demonstrate superiority of percutaneous posterior tibial nerve stimulation (PTNS) therapy compared to sham therapy for the treatment of patients with overall bladder (OAB) symptoms.

What is the current status of trial NCT00771264?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2008-09. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00771264?

The interventions under investigation include: Urgent PC Neuromodulation System (DEVICE).

Who is sponsoring clinical trial NCT00771264?

This trial is sponsored by Uroplasty, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00771264's enrollment target sits among peer trials

220 385th of 2000 higher than 1,612 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00771264, the US trial registry maintained by the National Library of Medicine. NCT00771264 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.